Cubist Systematic Strategies’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-499,021
| Closed | -$39.3M | – | 3329 |
|
|
2025
Q2 | $40.1M | Buy |
499,021
+386,236
| +342% | +$29.8M | 0.18% | 116 |
|
|
2025
Q1 | $9.06M | Buy |
+112,785
| New | +$9.38M | 0.05% | 532 |
|
|
2024
Q2 | – | Sell |
-95,826
| Closed | -$6.84M | – | 3610 |
|
|
2024
Q1 | $7.1M | Sell |
95,826
-48,953
| -34% | -$3.41M | 0.04% | 730 |
|
|
2023
Q4 | $9.57M | Buy |
144,779
+30,073
| +26% | +$1.88M | 0.06% | 474 |
|
|
2023
Q3 | $7.22M | Sell |
114,706
-505,215
| -81% | -$31.5M | 0.05% | 548 |
|
|
2023
Q2 | $35M | Buy |
619,921
+329,944
| +114% | +$18.3M | 0.23% | 48 |
|
|
2023
Q1 | $16.8M | Sell |
289,977
-178,413
| -38% | -$12M | 0.1% | 207 |
|
|
2022
Q4 | $33.9M | Buy |
468,390
+430,581
| +1,139% | +$30.8M | 0.2% | 35 |
|
|
2022
Q3 | $2.3M | Sell |
37,809
-27,693
| -42% | -$1.77M | 0.01% | 1863 |
|
|
2022
Q2 | $4.11M | Sell |
65,502
-12,501
| -16% | -$828K | 0.03% | 1165 |
|
|
2022
Q1 | $5.48M | Sell |
78,003
-33,377
| -30% | -$2.26M | 0.05% | 654 |
|
|
2021
Q4 | $6.96M | Sell |
111,380
-112,020
| -50% | -$7.03M | 0.07% | 443 |
|
|
2021
Q3 | $13.8M | Sell |
223,400
-50,971
| -19% | -$3.07M | 0.17% | 96 |
|
|
2021
Q2 | $16.4M | Buy |
274,371
+212,938
| +347% | +$13.5M | 0.19% | 91 |
|
|
2021
Q1 | $3.73M | Buy |
61,433
+7,392
| +14% | +$408K | 0.05% | 599 |
|
|
2020
Q4 | $2.54M | Sell |
54,041
-103,939
| -66% | -$4.5M | 0.03% | 802 |
|
|
2020
Q3 | $5.87M | Buy |
157,980
+112,728
| +249% | +$4.28M | 0.09% | 333 |
|
|
2020
Q2 | $1.65M | Buy |
45,252
+23,820
| +111% | +$829K | 0.03% | 911 |
|
|
2020
Q1 | $655K | Sell |
21,432
-299,121
| -93% | -$13.3M | 0.02% | 1092 |
|
|
2019
Q4 | $16.3M | Buy |
320,553
+133,164
| +71% | +$6.43M | 0.3% | 38 |
|
|
2019
Q3 | $8.84M | Buy |
187,389
+166,301
| +789% | +$7.93M | 0.18% | 132 |
|
|
2019
Q2 | $1.05M | Sell |
21,088
-4,532
| -18% | -$213K | 0.02% | 1014 |
|
|
2019
Q1 | $1.09M | Buy |
25,620
+19,253
| +302% | +$851K | 0.04% | 720 |
|
|
2018
Q4 | $261K | Sell |
6,367
-37,408
| -85% | -$1.61M | 0.01% | 1373 |
|
|
2018
Q3 | $2.04M | Sell |
43,775
-50,558
| -54% | -$2.31M | 0.11% | 208 |
|
|
2018
Q2 | $4.11M | Buy |
94,333
+28,211
| +43% | +$1.32M | 0.21% | 95 |
|
|
2018
Q1 | $3.03M | Sell |
66,122
-17,209
| -21% | -$835K | 0.18% | 124 |
|
|
2017
Q4 | $4.21M | Buy |
83,331
+62,679
| +304% | +$3.3M | 0.22% | 61 |
|
|
2017
Q3 | $1.07M | Sell |
20,652
-7,023
| -25% | -$342K | 0.06% | 399 |
|
|
2017
Q2 | $1.35M | Buy |
27,675
+27,022
| +4,138% | +$1.25M | 0.09% | 308 |
|
|
2017
Q1 | $31K | Sell |
653
-35,471
| -98% | -$1.69M | ﹤0.01% | 1521 |
|
|
2016
Q4 | $1.74M | Buy |
36,124
+27,794
| +334% | +$1.27M | 0.14% | 185 |
|
|
2016
Q3 | $330K | Sell |
8,330
-43,000
| -84% | -$1.62M | 0.02% | 952 |
|
|
2016
Q2 | $1.82M | Buy |
51,330
+20,854
| +68% | +$813K | 0.11% | 229 |
|
|
2016
Q1 | $1.19M | Sell |
30,476
-2,976
| -9% | -$111K | 0.07% | 386 |
|
|
2015
Q4 | $1.44M | Buy |
33,452
+1,755
| +6% | +$77.2K | 0.08% | 326 |
|
|
2015
Q3 | $1.33M | Sell |
31,697
-94,797
| -75% | -$4.43M | 0.07% | 427 |
|
|
2015
Q2 | $6.31M | Buy |
126,494
+65,948
| +109% | +$3.12M | 0.31% | 41 |
|
|
2015
Q1 | $2.73M | Sell |
60,546
-7,157
| -11% | -$322K | 0.13% | 176 |
|
|
2014
Q4 | $3.26M | Buy |
67,703
+24,825
| +58% | +$1.18M | 0.18% | 119 |
|
|
2014
Q3 | $2.05M | Buy |
42,878
+17,317
| +68% | +$841K | 0.13% | 209 |
|
|
2014
Q2 | $1.27M | Buy |
+25,561
| New | +$1.2M | 0.08% | 383 |
|
Other funds holding MET
Cubist Systematic Strategies's MET Position: Q3 2025 in Review
Cubist Systematic Strategies sold out of MetLife (MET) in Q3 2025, closing a stake of 499,021 shares — an estimated $39.3M sold.
Cubist Systematic Strategies first reported a position in MET in Q2 2014 and held it in 42 quarters. The position peaked at $40.1M in Q2 2025. 1,363 funds tracked by Wall St. Rank hold MET as of Q3 2025.
- Cubist Systematic Strategies reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
- Cubist Systematic Strategies sold 499,021 MetLife shares in Q3 2025, an estimated $39.3M.
- Cubist Systematic Strategies first reported a position in MetLife in Q2 2014 and held it in 42 quarters.
- Cubist Systematic Strategies's MetLife position peaked at $40.1M in Q2 2025.
- 1,363 funds tracked by Wall St. Rank held MetLife as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.